Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines <it>in vitro </it>and in <it>scid </it>mice
<p>Abstract</p> <p>Background</p> <p>Despite exciting new targeted therapeutics against non-Hodgkin's lymphoma (NHL), chemotherapy remains a cornerstone of therapy. While purine nucleoside analogs have significant activity in low grade NHL, the pyrimidine nucleoside analog gemcitabine has been less...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2005-08-01
|
| Serie: | BMC Cancer |
| Accesso online: | http://www.biomedcentral.com/1471-2407/5/103 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|